Markus Kohlmann

982 total citations
24 papers, 513 citations indexed

About

Markus Kohlmann is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Markus Kohlmann has authored 24 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Markus Kohlmann's work include Mass Spectrometry Techniques and Applications (2 papers), Peptidase Inhibition and Analysis (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Markus Kohlmann is often cited by papers focused on Mass Spectrometry Techniques and Applications (2 papers), Peptidase Inhibition and Analysis (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Markus Kohlmann collaborates with scholars based in Germany, France and United States. Markus Kohlmann's co-authors include Claus Wasternack, Ivo Feußner, Heiko Weichert, Aimo Kannt, A. Kolbe, Wolfgang Linz, P. Campı́ns-Falcó, Andreas Evers, C. Molins‐Legua and Herman Schreuder and has published in prestigious journals such as Hypertension, Journal of Medicinal Chemistry and European Journal of Biochemistry.

In The Last Decade

Markus Kohlmann

20 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Kohlmann Germany 14 221 102 64 48 46 24 513
Miriam Cantore Italy 11 336 1.5× 127 1.2× 70 1.1× 38 0.8× 13 0.3× 19 711
Takeshi Nishii Japan 11 297 1.3× 185 1.8× 68 1.1× 43 0.9× 15 0.3× 25 683
Shailendra Kumar Maurya India 16 245 1.1× 39 0.4× 64 1.0× 96 2.0× 15 0.3× 39 699
G. Graff United States 13 288 1.3× 68 0.7× 99 1.5× 40 0.8× 64 1.4× 27 660
Claire Colas United States 18 484 2.2× 56 0.5× 29 0.5× 22 0.5× 56 1.2× 29 801
Leslie A. Bateman United States 13 478 2.2× 199 2.0× 160 2.5× 53 1.1× 31 0.7× 17 815
Gary A. Radke United States 18 449 2.0× 37 0.4× 115 1.8× 46 1.0× 60 1.3× 31 782
Tadafumi Tamura Japan 16 149 0.7× 116 1.1× 111 1.7× 41 0.9× 32 0.7× 29 701
Hiroshi Fukumi Japan 12 440 2.0× 135 1.3× 37 0.6× 44 0.9× 16 0.3× 32 890
Mieczysław Puchała Poland 15 190 0.9× 161 1.6× 121 1.9× 36 0.8× 18 0.4× 35 581

Countries citing papers authored by Markus Kohlmann

Since Specialization
Citations

This map shows the geographic impact of Markus Kohlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Kohlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Kohlmann more than expected).

Fields of papers citing papers by Markus Kohlmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Kohlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Kohlmann. The network helps show where Markus Kohlmann may publish in the future.

Co-authorship network of co-authors of Markus Kohlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Kohlmann. A scholar is included among the top collaborators of Markus Kohlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Kohlmann. Markus Kohlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leeuw, Thomas, Deimantė Šimaitė, Karen Heyninck, et al.. (2025). Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa. Journal of Allergy and Clinical Immunology Global. 4(3). 100483–100483. 3 indexed citations
2.
Nassr, Nassr, Faı̈za Rharbaoui, Dietmar Weitz, et al.. (2025). First‐in‐Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy Participants. Clinical Pharmacology & Therapeutics. 118(1). 164–176.
3.
4.
5.
Margerie, Daniel, Christian Asbrand, Virginia Savova, et al.. (2023). Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis. Science Translational Medicine. 15(681). eabq4419–eabq4419. 44 indexed citations
6.
Ackerson, Timothy, Alexander Amberg, Jens Atzrodt, et al.. (2019). Mechanistic investigations of the liver toxicity of the free fatty acid receptor 1 agonist fasiglifam (TAK875) and its primary metabolites. Journal of Biochemical and Molecular Toxicology. 33(8). e22345–e22345. 22 indexed citations
7.
Hauske, Sibylle J., Shiqi Zhang, Thomas Albrecht, et al.. (2018). Identification and characterisation of carnostatine (SAN9812), a potent and selective carnosinase (CN1) inhibitor with in vivo activity. Amino Acids. 51(1). 7–16. 32 indexed citations
8.
Halland, Nis, Mark Brönstrup, Jörg Czech, et al.. (2015). Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin. Journal of Medicinal Chemistry. 58(11). 4839–4844. 37 indexed citations
9.
Hu, Hai‐Yu, Ngee Han Lim, Peter Florian, et al.. (2015). In vivo visualization of osteoarthritic hypertrophic lesions. Chemical Science. 6(11). 6256–6261. 21 indexed citations
10.
Ma, Li, et al.. (2014). Mass Spectrometric Analysis of Noncovalent Complexes Between Synthetic Peptides from Human Ribosomal Protein L7 and Protein G. Journal of Liquid Chromatography & Related Technologies. 38(10). 1007–1013.
11.
Zöller, G., Hans Matter, Andreas W. Herling, et al.. (2013). Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1). European Journal of Pharmacology. 707(1-3). 140–146. 10 indexed citations
12.
Matter, Hans, G. Zöller, Andreas W. Herling, et al.. (2013). Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization. Bioorganic & Medicinal Chemistry Letters. 23(6). 1817–1822. 9 indexed citations
13.
Ruf, Sven, Christian Buning, Herman Schreuder, et al.. (2012). Novel β-Amino Acid Derivatives as Inhibitors of Cathepsin A. Journal of Medicinal Chemistry. 55(17). 7636–7649. 39 indexed citations
14.
Zech, Gernot, Gerhard Heßler, Andreas Evers, et al.. (2012). Identification of High-Affinity P2Y12Antagonists Based on a Phenylpyrazole Glutamic Acid Piperazine Backbone. Journal of Medicinal Chemistry. 55(20). 8615–8629. 30 indexed citations
15.
Löhn, Matthias, Oliver Plettenburg, Yuri Ivashchenko, et al.. (2009). Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor. Hypertension. 54(3). 676–683. 77 indexed citations
16.
Macht, Marcus, Andreas Marquardt, Sören‐Oliver Deininger, et al.. (2003). "Affinity-proteomics": direct protein identification from biological material using mass spectrometric epitope mapping. Analytical and Bioanalytical Chemistry. 378(4). 1102–1111. 27 indexed citations
17.
Kohlmann, Markus, et al.. (1999). Formation of lipoxygenase‐pathway‐derived aldehydes in barley leaves upon methyl jasmonate treatment. European Journal of Biochemistry. 260(3). 885–895. 65 indexed citations
18.
Louis, Dominique, Markus Kohlmann, & Jean Wallach. (1997). Spectrophotometric assay for amidolytic activity of alkaline protease from Pseudomonas aeruginosa. Analytica Chimica Acta. 345(1-3). 219–225. 8 indexed citations
19.
Campı́ns-Falcó, P., Adela Sevillano-Cabeza, C. Molins‐Legua, & Markus Kohlmann. (1996). Amphetamine and methamphetamine determination in urine by reversed-phase high-performance liquid chromatography with simultaneous sample clean-up and derivatization with naphthoquinone 4-sulphonate on solid-phase cartridges. Journal of Chromatography B Biomedical Sciences and Applications. 687(1). 239–246. 28 indexed citations
20.
Kohlmann, Markus, et al.. (1994). Structure of a Y1−x(Gd,Dy,Er)xPO4.2H2O microcrystal using synchrotron radiation. Acta Crystallographica Section C Crystal Structure Communications. 50(11). 1651–1652. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miriam Cantore Breakdown of academic impact, for papers by Takeshi Nishii Breakdown of academic impact, for papers by Shailendra Kumar Maurya Breakdown of academic impact, for papers by G. Graff Breakdown of academic impact, for papers by Claire Colas Breakdown of academic impact, for papers by Leslie A. Bateman Breakdown of academic impact, for papers by Gary A. Radke Breakdown of academic impact, for papers by Tadafumi Tamura Breakdown of academic impact, for papers by Hiroshi Fukumi Breakdown of academic impact, for papers by Mieczysław Puchała
Rankless by CCL
2026